7Baggers
 Salarius: Q3 Earnings Snapshot  Stamford Advocate Sat, 15 Nov 2025 06:19:23 GMT
 Salarius: Q3 Earnings Snapshot  KTEN Fri, 14 Nov 2025 22:35:11 GMT
 Salarius Pharmaceuticals, Inc. SEC 10-Q Report  TradingView Fri, 14 Nov 2025 22:33:01 GMT
 Salarius Pharmaceuticals Completes $7M Offering and Merger  TipRanks Thu, 13 Nov 2025 21:36:46 GMT
 Salarius Pharmaceuticals Completes Merger With Decoy Therapeutics  MarketScreener Thu, 13 Nov 2025 19:36:11 GMT
 3 Penny Stocks to Watch Now, 11/13/25  TipRanks Thu, 13 Nov 2025 15:02:57 GMT
 Salarius jumps after completing merger with Decoy Therapeutics  TradingView Thu, 13 Nov 2025 14:38:03 GMT
 salarius pharmaceuticals (slrx) completes merger with decoy ther  GuruFocus Thu, 13 Nov 2025 14:32:22 GMT
 Salarius Pharmaceuticals, Decoy Therapeutics complete merger  TipRanks Thu, 13 Nov 2025 13:55:04 GMT
 Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger  Yahoo Finance Thu, 13 Nov 2025 13:45:00 GMT
 salarius stock slides after pricing $7m offering  MSN Thu, 13 Nov 2025 13:43:45 GMT
 12 health care stocks moving in wednesday's intraday session  Benzinga Wed, 12 Nov 2025 17:05:53 GMT
 Salarius Pharmaceuticals Explorates Merger and Funding Moves  StocksToTrade Wed, 12 Nov 2025 15:04:00 GMT
 Salarius Pharmaceuticals Upcoming Merger: What to Expect?  timothysykes.com Wed, 12 Nov 2025 14:19:00 GMT
 Why Is Salarius Pharmaceuticals Stock (SLRX) Up 65% Today?  TipRanks Wed, 12 Nov 2025 12:52:30 GMT
 pre market movers: slrx, si, eldn swing big  RTTNews Wed, 12 Nov 2025 12:40:00 GMT
 Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?  Benzinga Wed, 12 Nov 2025 03:31:59 GMT
 salarius stock slides after pricing $7m offering  MSN Wed, 12 Nov 2025 00:20:32 GMT
 Salarius stock slides after pricing $7M offering  MSN Tue, 11 Nov 2025 17:21:51 GMT
 salarius pharmaceuticals prices $7 million public offering  MarketScreener Tue, 11 Nov 2025 16:39:13 GMT
 salarius prices $7 million public offering of shares and warrants by investing.com  Investing.com Nigeria Tue, 11 Nov 2025 15:27:28 GMT
 Salarius Pharmaceuticals (SLRX) Announces $7M Public Offering  GuruFocus Tue, 11 Nov 2025 14:56:48 GMT
 published on: 2025-11-10 03:41:55  newser.com Mon, 10 Nov 2025 09:41:55 GMT
 published on: 2025-11-05 20:37:24  Fundação Cultural do Pará Wed, 05 Nov 2025 11:39:09 GMT

Salarius Pharmaceuticals, Inc
(NASDAQ:SLRX) 

SLRX stock logo

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. The company's lead candidate is Seclidemstat (SP-2577), which is in Phase I/II clinical trial for the treatment of advanced solid tumors, including prostate, breast, and ...

Founded: 2014
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends